Literature DB >> 34744354

EBV Negative Angioimmunoblastic T-Cell Lymphoma with Sequential Development of Diffuse Large B-Cell Lymphoma in Course of Progression.

Ivan Petković1,2, Slavica Stojnev1,3, Aleksandar Popović2, Miljan Krstić1,3, Ivica Pejčić1,2.   

Abstract

Entities:  

Keywords:  Angioimmunoblastic T; Barr virus; Cell lymphoma; Epstein; diffuse large B

Year:  2021        PMID： 34744354      PMCID： PMC8523641          DOI： 10.1007/s12288-021-01425-w

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN： 0971-4502            Impact factor:   0.915


× No keyword cloud information.
  4 in total

Review 1.  The 2016 revision of the World Health Organization classification of lymphoid neoplasms.

Authors:  Steven H Swerdlow; Elias Campo; Stefano A Pileri; Nancy Lee Harris; Harald Stein; Reiner Siebert; Ranjana Advani; Michele Ghielmini; Gilles A Salles; Andrew D Zelenetz; Elaine S Jaffe
Journal:  Blood       Date:  2016-03-15       Impact factor: 22.113

2.  A Case of Cutaneous Epstein-Barr Virus-Associated Diffuse Large B-Cell Lymphoma in an Angioimmunoblastic T-Cell Lymphoma.

Authors:  Mi-Hye Lee; Ik-Jun Moon; Woo-Jin Lee; Chong-Hyun Won; Sung-Eun Chang; Jee-Ho Choi; Mi-Woo Lee
Journal:  Ann Dermatol       Date:  2016-11-23       Impact factor: 1.444

3.  Sequential development of diffuse large B-cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma.

Authors:  Jing Huang; Pei-Hong Zhang; Yu-Huan Gao; Lu-Gui Qiu
Journal:  Diagn Cytopathol       Date:  2011-04-06       Impact factor: 1.582

4.  Epstein-Barr virus negative clonal plasma cell proliferations and lymphomas in peripheral T-cell lymphomas: a phenomenon with distinctive clinicopathologic features.

Authors:  Olga Balagué; Antonio Martínez; Luís Colomo; Ester Roselló; Adriana Garcia; Mónica Martínez-Bernal; Antonio Palacín; Kai Fu; Dennis Weisenburger; Dolors Colomer; Jerome S Burke; Roger A Warnke; Elías Campo
Journal:  Am J Surg Pathol       Date:  2007-09       Impact factor: 6.394
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.